Molecular profiling of triple negative breast cancer

Breast Disease

Volumn 32, Issue 1-2, 2010, Pages 73-84

  Ma, Cynthia X ^a,b   Luo, Jingqin ^a,b   Ellis, Matthew J ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; BRCA1 PROTEIN; CLAUDIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PROGESTERONE RECEPTOR; TAXANE DERIVATIVE; TRANSCRIPTOME;

ADJUVANT THERAPY; APOCRINE GLAND; ARTICLE; BASAL LIKE BREAST CANCER; BIOINFORMATICS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GENETICS; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; DRUG EFFICACY; DRUG TARGETING; EXON; GENE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC DISORDER; GENOME ANALYSIS; GENOMICS; GERM LINE; HER2 GENE; HIGH THROUGHPUT SCREENING; HUMAN; MEDICAL TECHNOLOGY; METHYLATION; MOLECULAR BIOLOGY; MOLECULAR GENETICS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; TREATMENT RESPONSE; TRIPLE NEGATIVE BREAST CANCER; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENES, BRCA1; HUMANS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 80755129040     PISSN: 08886008     EISSN: 15581551     Source Type: Journal    
DOI: 10.3233/BD-2010-0309     Document Type: Article

References (81)

1. U. Bilitewski, DNA microarrays: an introduction to the technology, Methods Mol Biol 509 (2009), 1-14.
2. D.J. Lockhart, H. Dong, M.C. Byrne, M.T. Follettie, M.V. Gallo, M.S. Chee, M. Mittmann, C. Wang, M. Kobayashi, H. Horton and E.L. Brown, Expression monitoring by hybridization to high-density oligonucleotide arrays, Nat Biotechnol 14 (1996), 1675-1680. (Pubitemid 26414810)
3. C. April, B. Klotzle, T. Royce, E. Wickham-Garcia, T. Boyaniwsky, J. Izzo, D. Cox, W. Jones, R. Rubio, K. Holton, U. Matulonis, J. Quackenbush and J.B. Fan,Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples, PLoS One 4 (2009), e8162.
4. F.E. Ahmed, Microarray RNA transcriptional profiling: part I. Platforms, experimental design and standardization, Expert Rev Mol Diagn 6 (2006), 535-550. (Pubitemid 44179940)
5. R.D. Canales, Y. Luo, J.C. Willey, B. Austermiller, C.C. Barbacioru, C. Boysen, K. Hunkapiller, R.V. Jensen, C.R. Knight, K.Y. Lee, Y. Ma, B. Maqsodi, A. Papallo, E.H. Peters, K. Poulter, P.L. Ruppel, R.R. Samaha, L. Shi,W. Yang, L. Zhang and F.M. Goodsaid, Evaluation of DNA microarray results with quantitative gene expression platforms, Nat Biotechnol 24 (2006), 1115-1122. (Pubitemid 44359723)
6. B.S. Everitt, S. Landau andM. Leese, Cluster Analysis, Heinemann Educational Books, London, 1974.
7. M.B. Eisen, P.T. Spellman, P.O. Brown and D. Botstein, Cluster analysis and display of genome-wide expression patterns, Proc Natl Acad Sci USA 95 (1998), 14863-14868. (Pubitemid 29003722)
8. C.M. Perou, T. Sorlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, C.A. Rees, J.R. Pollack, D.T. Ross, H. Johnsen, L.A. Akslen, O. Fluge, A. Pergamenschikov, C. Williams, S.X. Zhu, P.E. Lonning, A.L. Borresen-Dale, P.O. Brown and D. Botstein, Molecular portraits of human breast tumours, Nature 406 (2000), 747-752.
9. T. Sorlie, C.M. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, T. Thorsen, H. Quist, J.C. Matese, P.O. Brown, D. Botstein, P. Eystein Lonning and A.L. Borresen-Dale, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci USA 98 (2001), 10869-10874. (Pubitemid 32878711)
10. T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J.S. Marron, A. Nobel, S. Deng, H. Johnsen, R. Pesich, S. Geisler, J. Demeter, C.M. Perou, P.E. Lonning, P.O. Brown, A.L. Borresen Dale and D. Botstein, Repeated observation of breast tumor subtypes in independent gene expression data sets, Proc Natl Acad Sci USA 100 (2003), 8418-8423. (Pubitemid 36842560)
11. Y. Benjamini, D. Drai, G. Elmer, N. Kafkafi and I. Golani, Controlling the false discovery rate in behavior genetics research, Behav Brain Res 125 (2001), 279-284. (Pubitemid 33000466)
12. J.D. Storey and R. Tibshirani, Statistical significance for genomewide studies, Proc Natl Acad Sci USA 100 (2003), 9440-9445. (Pubitemid 37033947)
13. V.G. Tusher, R. Tibshirani and G. Chu, Significance analysis of microarrays applied to the ionizing radiation response, Proc Natl Acad Sci USA 98 (2001), 5116-5121. (Pubitemid 32397092)
14. S. Paik, S. Shak, G. Tang, C. Kim, J. Baker, M. Cronin, F.L. Baehner, M.G. Walker, D. Watson, T. Park, W. Hiller, E.R. Fisher, D.L. Wickerham, J. Bryant and N. Wolmark, A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer, N Engl J Med 351 (2004), 2817-2826. (Pubitemid 40051905)
15. Z. Hu, C. Fan, D.S. Oh, J.S. Marron, X. He, B.F. Qaqish, C. Livasy, L.A. Carey, E. Reynolds, L. Dressler, A. Nobel, J. Parker, M.G. Ewend, L.R. Sawyer, J. Wu, Y. Liu, R. Nanda, M. Tretiakova, A. Ruiz Orrico, D. Dreher, J.P. Palazzo, L. Perreard, E. Nelson, M. Mone, H. Hansen, M. Mullins, J.F. Quackenbush, M.J. Ellis, O.I. Olopade, P.S. Bernard and C.M. Perou, The molecular portraits of breast tumors are conserved across microarray platforms, BMC Genomics 7 (2006), 96.
16. C.M. Perou, J.S. Parker, A. Prat, M.J. Ellis and P.S. Bernard, Clinical implementation of the intrinsic subtypes of breast cancer, Lancet Oncol 11 (2010), 718-719; author reply 720-711.
17. H.Y. Chang, D.S. Nuyten, J.B. Sneddon, T. Hastie, R. Tibshirani, T. Sorlie, H. Dai, Y.D. He, L.J. van't Veer, H. Bartelink, M. van de Rijn, P.O. Brown and M.J. van de Vijver, Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival, Proc Natl Acad Sci USA 102 (2005), 3738-3743. (Pubitemid 40354681)
18. J.T. Chi, Z.Wang, D.S. Nuyten, E.H. Rodriguez, M.E. Schaner, A. Salim, Y. Wang, G.B. Kristensen, A. Helland, A.L. Borresen-Dale, A. Giaccia, M.T. Longaker, T. Hastie, G.P. Yang, M.J. van de Vijver and P.O. Brown, Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers, PLoSMed 3 (2006), e47.
19. R. Liu, X. Wang, G.Y. Chen, P. Dalerba, A. Gurney, T. Hoey, G. Sherlock, J. Lewicki, K. Shedden and M.F. Clarke, The prognostic role of a gene signature from tumorigenic breastcancer cells, N Engl J Med 356 (2007), 217-226. (Pubitemid 46143225)
20. L.D. Miller, J. Smeds, J. George, V.B. Vega, L. Vergara, A. Ploner, Y. Pawitan, P. Hall, S. Klaar, E.T. Liu and J. Bergh, An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival, Proc Natl Acad Sci USA 102 (2005), 13550-13555. (Pubitemid 41420886)
21. Y. Wang, J.G. Klijn, Y. Zhang, A.M. Sieuwerts, M.P. Look, F. Yang, D. Talantov, M. Timmermans, M.E. Meijer-van Gelder, J. Yu, T. Jatkoe, E.M. Berns, D. Atkins and J.A. Foekens, Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer, Lancet 365 (2005), 671-679. (Pubitemid 40260888)
22. C. Desmedt, E. Ruiz-Garcia and F. Andre, Gene expression predictors in breast cancer: current status, limitations and perspectives, Eur J Cancer 44 (2008), 2714-2720.
23. C. Fan, D.S. Oh, L. Wessels, B. Weigelt, D.S. Nuyten, A.B. Nobel, L.J. van't Veer and C.M. Perou, Concordance among gene-expression-based predictors for breast cancer, N Engl J Med 355 (2006), 560-569. (Pubitemid 44200649)
24. B.T. Hennessy, A.M. Gonzalez-Angulo, K. Stemke-Hale, M.Z. Gilcrease, S. Krishnamurthy, J.S. Lee, J. Fridlyand, A. Sahin, R. Agarwal, C. Joy, W. Liu, D. Stivers, K. Baggerly, M. Carey, A. Lluch, C. Monteagudo, X. He, V. Weigman, C. Fan, J. Palazzo, G.N. Hortobagyi, L.K. Nolden, N.J.Wang, V. Valero, J.W. Gray, C.M. Perou and G.B. Mills, Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics, Cancer Res 69 (2009), 4116-4124.
25. J.I. Herschkowitz, K. Simin, V.J. Weigman, I. Mikaelian, J. Usary, Z. Hu, K.E. Rasmussen, L.P. Jones, S. Assefnia, S. Chandrasekharan, M.G. Backlund, Y. Yin, A.I. Khramtsov, R. Bastein, J. Quackenbush, R.I. Glazer, P.H. Brown, J.E. Green, L. Kopelovich, P.A. Furth, J.P. Palazzo, O.I. Olopade, P.S. Bernard, G.A. Churchill, T. Van Dyke and C.M. Perou, Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors, Genome Biol 8 (2007), R76.
26. A. Prat and C.M. Perou, Mammary development meets cancer genomics, Nat Med 15 (2009), 842-844.
27. A. Prat, J. Parker, O. Karginova, C. Fan, C. Livasy, J. Herschkowitz, X. He and C. Perou, Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer, Breast Cancer Research 12 (2010), R68.
28. P. Farmer, H. Bonnefoi, V. Becette, M. Tubiana-Hulin, P. Fumoleau, D. Larsimont, G. Macgrogan, J. Bergh, D. Cameron, D. Goldstein, S. Duss, A.L. Nicoulaz, C. Brisken, M. Fiche, M. Delorenzi and R. Iggo, Identification ofmolecular apocrine breast tumours by microarray analysis, Oncogene 24 (2005), 4660-4671. (Pubitemid 41032603)
29. B.Weigelt, H.M.Horlings, B.Kreike, M.M. Hayes, M. Hauptmann, L.F.Wessels, D. de Jong, M.J. Van de Vijver, L.J. Van't Veer and J.L. Peterse, Refinement of breast cancer classification by molecular characterization of histological special types, J Pathol 216 (2008), 141-150.
30. A.E. Teschendorff, A.Miremadi, S.E. Pinder, I.O. Ellis and C. Caldas, An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer, Genome Biol 8 (2007), R157.
31. A.S. Doane, M. Danso, P. Lal, M. Donaton, L. Zhang, C. Hudis and W.L. Gerald, An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen, Oncogene 25 (2006), 3994-4008. (Pubitemid 43990755)
32. S. Sanga, B.M. Broom, V. Cristini and M.E. Edgerton, Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family, BMC Med Genomics 2 (2009), 59.
33. J.S. Parker, M. Mullins, M.C. Cheang, S. Leung, D. Voduc, T. Vickery, S. Davies, C. Fauron, X. He, Z. Hu, J.F. Quackenbush, I.J. Stijleman, J. Palazzo, J.S.Marron, A.B. Nobel, E. Mardis, T.O.Nielsen, M.J. Ellis, C.M. Perou and P.S. Bernard, Supervised risk predictor of breast cancer based on intrinsic subtypes, J Clin Oncol 27 (2009), 1160-1167.
34. A. Bergamaschi, Y.H. Kim, P.Wang, T. Sorlie, T. Hernandez- Boussard, P.E. Lonning, R. Tibshirani, A.L. Borresen-Dale and J.R. Pollack, Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer, Genes Chromosomes Cancer 45 (2006), 1033-1040. (Pubitemid 44435537)
35. S.H. Nordgard, F.E. Johansen,G.I.Alnaes, B.Naume andA.L. Borresen-Dale, V.N. Kristensen, Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes, Breast Cancer Res 9 (2007), 113.
36. A.H. Sims, A. Howell, S.J. Howell and R.B. Clarke, Origins of breast cancer subtypes and therapeutic implications, Nat Clin Pract Oncol 4 (2007), 516-525. (Pubitemid 47351462)
37. E. Lim, F. Vaillant, D. Wu, N.C. Forrest, B. Pal, A.H. Hart, M.L. Asselin-Labat, D.E. Gyorki, T. Ward, A. Partanen, F. Feleppa, L.I. Huschtscha, H.J. Thorne, S.B. Fox, M. Yan, J.D. French, M.A. Brown, G.K. Smyth, J.E. Visvader and G.J. Lindeman, Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers, Nat Med 15 (2009), 907-913.
38. A. Raouf, Y. Zhao, K. To, J. Stingl, A.Delaney, M. Barbara, N. Iscove, S. Jones, S. McKinney, J. Emerman, S. Aparicio, M. Marra and C. Eaves, Transcriptome analysis of the normal human mammary cell commitment and differentiation process, Cell Stem Cell 3 (2008), 109-118.
39. B. Weigelt, A. Mackay, R. A'Hern, R. Natrajan, D.S. Tan, M. Dowsett, A. Ashworth and J.S. Reis-Filho, Breast cancer molecular profiling with single sample predictors: a retrospective analysis, Lancet Oncol 11 (2010), 339-349.
40. J. Staaf, M. Ringner, J. Vallon-Christersson, G. Jonsson, P.O. Bendahl, K. Holm, A. Arason, H. Gunnarsson, C. Hegardt, B.A. Agnarsson, L. Luts, D. Grabau, M. Ferno, P.O. Malmstrom, O.T. Johannsson, N. Loman, R.B. Barkardottir, and A. Borg, Identification of subtypes in human epidermal growth factor receptor 2-positive breast cancer reveals a gene signature prognostic of outcome, J Clin Oncol 28 (2010), 1813-1820.
41. C.J. Creighton, J.C. Chang and J.M. Rosen, Epithelialmesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer, J Mammary Gland Biol Neoplasia 15 (2010), 253-260.
42. F. Bertucci, P. Finetti, N. Cervera, B. Esterni, F. Hermitte, P. Viens and D. Birnbaum, How basal are triple-negative breast cancers? Int J Cancer 123 (2008), 236-240. (Pubitemid 351705215)
43. B. Kreike, M. van Kouwenhove, H. Horlings, B. Weigelt, H. Peterse, H. Bartelink and M.J. van de Vijver, Gene expression profiling and histopathological characterization of triplenegative/ basal-like breast carcinomas, Breast Cancer Res 9 (2007), R65.
44. T.O. Nielsen, F.D. Hsu, K. Jensen, M. Cheang, G. Karaca, Z. Hu, T.Hernandez-Boussard, C. Livasy, D. Cowan, L.Dressler, L.A. Akslen, J. Ragaz, A.M. Gown, C.B. Gilks, M. van de Rijn and C.M. Perou, Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma, Clin Cancer Res 10 (2004), 5367-5374. (Pubitemid 39100473)
45. L.A. Carey, C.M. Perou, C.A. Livasy, L.G. Dressler, D. Cowan, K. Conway, G. Karaca, M.A. Troester, C.K. Tse, S. Edmiston, S.L. Deming, J. Geradts, M.C. Cheang, T.O. Nielsen, P.G. Moorman, H.S. Earp and R.C. Millikan, Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study, JAMA 295 (2006), 2492-2502. (Pubitemid 43854964)
46. C.A. Livasy, G. Karaca, R. Nanda, M.S. Tretiakova, O.I. Olopade, D.T. Moore and C.M. Perou, Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma, Mod Pathol 19 (2006), 264-271. (Pubitemid 43117611)
47. S.M. Rodriguez-Pinilla, D. Sarrio, E. Honrado, D. Hardisson, F. Calero, J. Benitez and J. Palacios, Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas, Clin Cancer Res 12 (2006), 1533-1539.
48. L.G. Fulford, D.F. Easton, J.S. Reis-Filho, A. Sofronis, C.E. Gillett, S.R. Lakhani and A. Hanby, Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast, Histopathology 49 (2006), 22-34. (Pubitemid 43972917)
49. H. Tsuda, T. Takarabe, F. Hasegawa, T. Fukutomi and S. Hirohashi, Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases, Am J Surg Pathol 24 (2000), 197-202. (Pubitemid 30078708)
50. B. Ghabach, W.F. Anderson, R.E. Curtis, M.M. Huycke, J.A. Lavigne and G.M. Dores, Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study, Breast Cancer Res 12 (2010), R54.
51. S.R. Lakhani, M.J. Van De Vijver, J. Jacquemier, T.J. Anderson, P.P. Osin, L. McGuffog and D.F. Easton, The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2, J Clin Oncol 20 (2002), 2310-2318. (Pubitemid 34441658)
52. +) phenotype of BRCA1-related breast cancer, Cancer Res 64 (2004), 830-835. (Pubitemid 38176880)
53. N. Turner, A. Tutt and A. Ashworth, Hallmarks of 'BRCAness' in sporadic cancers, Nat Rev Cancer 4 (2004), 814-819.
54. W.D. Foulkes, I.M. Stefansson, P.O. Chappuis, L.R. Begin, J.R. Goffin, N. Wong, M. Trudel and L.A. Akslen, Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer, J Natl Cancer Inst 95 (2003), 1482-1485. (Pubitemid 37279334)
55. T. Crook, S. Crossland, M.R. Crompton, P. Osin and B.A. Gusterson, p53 mutations in BRCA1-associated familial breast cancer, Lancet 350 (1997), 638-639. (Pubitemid 27367803)
56. S. Ganesan, D.P. Silver, R.A. Greenberg, D. Avni, R. Drapkin, A. Miron, S.C. Mok,V. Randrianarison, S. Brodie, J. Salstrom, T.P. Rasmussen, A. Klimke, C. Marrese, Y. Marahrens, C.X. Deng, J. Feunteun and D.M. Livingston, BRCA1 supports XIST RNA concentration on the inactive X chromosome, Cell 111 (2002), 393-405. (Pubitemid 35341392)
57. A.L. Richardson, Z.C.Wang, A. De Nicolo, X. Lu, M. Brown, A. Miron, X. Liao, J.D. Iglehart, D.M. Livingston and S. Ganesan, X chromosomal abnormalities in basal-like human breast cancer, Cancer Cell 9 (2006), 121-132. (Pubitemid 43202662)
58. P.A. Futreal, Q. Liu, D. Shattuck-Eidens, C. Cochran, K. Harshman, S. Tavtigian, L.M. Bennett, A. Haugen-Strano, J. Swensen, Y. Miki et al., BRCA1 mutations in primary breast and ovarian carcinomas, Science 266 (1994), 120-122. (Pubitemid 24345332)
59. A. Catteau,W.H.Harris, C.F. Xu and E. Solomon, Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics, Oncogene 18 (1999), 1957-1965. (Pubitemid 29150082)
60. M. Wei, T.A. Grushko, J. Dignam, F. Hagos, R. Nanda, L. Sveen, J. Xu, J. Fackenthal, M. Tretiakova, S. Das and O.I. Olopade, BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy, Cancer Res 65 (2005), 10692-10699. (Pubitemid 41713336)
61. J.J. Gorski, C.R. James, J.E. Quinn, G.E. Stewart, K.C. Staunton, N.E. Buckley, F.A. McDyer, R.D. Kennedy, R.H. Wilson, P.B. Mullan and D.P. Harkin, BRCA1 transcriptional ly regulates genes associated with the basal-like phenotype in breast cancer, Breast Cancer Res Treat 122 (2009), 721-731.
62. J.E. Quinn, R.D. Kennedy, P.B. Mullan, P.M. Gilmore, M. Carty, P.G. Johnston and D.P. Harkin, BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis, Cancer Res 63 (2003), 6221-6228. (Pubitemid 37255167)
63. P. Tassone, P. Tagliaferri, A. Perricelli, S. Blotta, B. Quaresima, M.L. Martelli, A. Goel, V. Barbieri, F. Costanzo, C.R. Boland and S. Venuta, BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells, Br J Cancer 88 (2003), 1285-1291. (Pubitemid 36606348)
64. R. Scully, S. Ganesan, K. Vlasakova, J. Chen, M. Socolovsky and D.M. Livingston, Genetic analysis of BRCA1 function in a defined tumor cell line, Mol Cell 4 (1999), 1093-1099. (Pubitemid 30054915)
65. S. Rottenberg, A.O. Nygren, M. Pajic, F.W. van Leeuwen, I. van der Heijden, K. van de Wetering, X. Liu, K.E. de Visser, K.G. Gilhuijs, O. van Tellingen, J.P. Schouten, J. Jonkers and P. Borst, Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer, Proc Natl Acad Sci USA 104 (2007), 12117-12122. (Pubitemid 47185639)
66. T. Byrski, J. Gronwald, T. Huzarski, E. Grzybowska, M. Budryk, M. Stawicka, T. Mierzwa, M. Szwiec, R. Wisniowski, M. Siolek, R. Dent, J. Lubinski and S. Narod, Pathologic Complete Response Rates in Young Women With BRCA1- Positive Breast Cancers After Neoadjuvant Chemotherapy, J Clin Oncol 28 (2010), 375-379.
67. D.P. Silver, A.L. Richardson, A.C. Eklund, Z.C. Wang, Z. Szallasi, Q. Li, N. Juul, C.O. Leong, D. Calogrias, A. Buraimoh, A. Fatima, R.S. Gelman, P.D. Ryan, N.M. Tung, A. De Nicolo, S. Ganesan, A. Miron, C. Colin, D.C. Sgroi, L.W. Ellisen, E.P. Winer, J.E. Garber, Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer, J Clin Oncol 28 (2010), 1145-1153.
68. K. Holm, C. Hegardt, J. Staaf, J. Vallon-Christersson, G. Jonsson, H. Olsson, A. Borg and M. Ringner, Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns, Breast Cancer Res 12 (2010), R36.
69. J.P.Venables, Aberrant and alternative splicing in cancer, Cancer Res 64 (2004), 7647-7654.
70. A. Bergamaschi, G.O. Hjortland, T. Triulzi, T. Sorlie, H. Johnsen, A.H. Ree, H.G. Russnes, S. Tronnes, G.M. Maelandsmo, O. Fodstad, A.L. Borresen-Dale andO. Engebraaten, Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models, Mol Oncol 3 (2009), 469-482.
71. Z.C. Wang, M. Lin, L.J. Wei, C. Li, A. Miron, G. Lodeiro, L. Harris, S. Ramaswamy, D.M. Tanenbaum, M. Meyerson, J.D. Iglehart and A. Richardson, Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers, Cancer Res 64 (2004), 64-71. (Pubitemid 38114083)
72. C. Jones, E. Ford, C. Gillett, K. Ryder, S. Merrett, J.S. Reis- Filho, L.G. Fulford, A. Hanby and S.R. Lakhani, Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes, Clin Cancer Res 10 (2004), 5988-5997. (Pubitemid 39287503)
73. L.W. Loo, D.I. Grove, E.M. Williams, C.L. Neal, L.A. Cousens, E.L. Schubert, I.N. Holcomb, H.F. Massa, J. Glogovac, C.I. Li, K.E.Malone, J.R. Daling, J.J. Delrow, B.J. Trask, L. Hsu and P.L. Porter, Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes, Cancer Res 64 (2004), 8541-8549. (Pubitemid 39552066)
74. X. Wang, L. Zou, H. Zheng, Q. Wei, S.J. Elledge and L. Li, Genomic instability and endoreduplication triggered by RAD17 deletion, Genes Dev 17 (2003), 965-970. (Pubitemid 36459449)
75. Y. Gao, D.O. Ferguson,W. Xie, J.P. Manis, J. Sekiguchi, K.M. Frank, J. Chaudhuri, J. Horner, R.A. DePinho and F.W. Alt, Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development, Nature 404 (2000), 897-900. (Pubitemid 30230344)
76. P.V. Jallepalli, I.C. Waizenegger, F. Bunz, S. Langer, M.R. Speicher, J.M. Peters, K.W. Kinzler, B. Vogelstein and C. Lengauer, Securin is required for chromosomal stability in human cells, Cell 105 (2001), 445-457. (Pubitemid 32520851)
77. M. Tirkkonen, O. Johannsson, B.A. Agnarsson, H. Olsson, S. Ingvarsson, R. Karhu, M. Tanner, J. Isola, R.B. Barkardottir, A. Borg and O.P. Kallioniemi, Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations, Cancer Res 57 (1997), 1222-1227. (Pubitemid 27152540)
78. K.L. Nathanson, Y.Y. Shugart, R. Omaruddin, C. Szabo, D. Goldgar, T.R. Rebbeck and B.L.Weber, CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5q, Hum Mol Genet 11 (2002), 1327-1332. (Pubitemid 34555530)
79. N. Turner, M.B. Lambros, H.M. Horlings, A. Pearson, R. Sharpe, R. Natrajan, F.C. Geyer, M. van Kouwenhove, B. Kreike, A. Mackay, A. Ashworth, M.J. van de Vijver and J.S. Reis-Filho, Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets, Oncogene 29 (2010), 2013-2023.
80. L. Ding, M.J. Ellis, S. Li, D.E. Larson, K. Chen, J.W. Wallis, C.C. Harris, M.D. McLellan, R.S. Fulton, L.L. Fulton, R.M. Abbott, J. Hoog, D.J. Dooling, D.C. Koboldt, H. Schmidt, J. Kalicki, Q. Zhang, L. Chen, L. Lin, M.C. Wendl, J.F. McMichael, V.J. Magrini, L. Cook, S.D. McGrath, T.L. Vickery, E. Appelbaum, K. Deschryver, S. Davies, T. Guintoli, R. Crowder, Y. Tao, J.E. Snider, S.M. Smith, A.F. Dukes, G.E. Sanderson, C.S. Pohl, K.D. Delehaunty, C.C. Fronick, K.A. Pape, J.S. Reed, J.S. Robinson, J.S. Hodges, W. Schierding, N.D. Dees, D. Shen, D.P. Locke, M.E.Wiechert, J.M. Eldred, J.B. Peck, B.J. Oberkfell, J.T. Lolofie, F. Du, A.E. Hawkins, M.D. O'Laughlin, K.E. Bernard, M. Cunningham, G. Elliott, M.D. Mason, D.M. Thompson, Jr., J.L. ovich, P.J. Goodfellow, C.M. Perou, G.M. Weinstock, R. Aft, M. Watson, T.J. Ley, R.K. Wilson and E.R. Mardis, Genome remodelling in a basal-like breast cancer metastasis and xenograft, Nature 464 (2010), 999-1005.
81. C. Speers, A. Tsimelzon, K. Sexton, A.M. Herrick, C. Gutierrez, A. Culhane, J. Quackenbush, S. Hilsenbeck, J. Chang and P. Brown, Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancer, Clin Cancer Res 15 (2009), 6327-6340.